Evonik expands lipid-based drug delivery capabilities with new GMP manufacturing facility in Vancouver
Evonik is investing in a new GMP drug product manufacturing facility for lipid-based drug delivery in Vancouver, Canada. The facility will increase Evonik’s development and manufacturing capacity, helping pharmaceutical and biotech customers bring lipid-based pharmaceutical products including vaccines, therapeutics, and other advanced medicines from development through commercial scale.